H.Res. 709 · 113th Congress
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a ''Valley of Death'' in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
- Stage
- In committee
- Sponsor
- Juan Vargas
- Introduced
- 2014-07-31
- Latest action
- 2014-08-01 · Referred to the Subcommittee on Health.
Subjects
Executive agency funding and structure
Health
Medical research
Health programs administration and funding
Research administration and funding
Department of Health and Human Services
Health technology, devices, supplies
Research and development
Advanced technology and technological innovations
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Biological and life sciences